Cite
Zhao Z, Cai T, Chen H, et al. Expert consensus on the use of omalizumab in chronic urticaria in China. World Allergy Organ J. 2021;14(11):100610doi: 10.1016/j.waojou.2021.100610.
Zhao, Z., Cai, T., Chen, H., Chen, L., Chen, Y., Gao, X., Gao, X., Geng, S., Guo, Y., Hao, F., Hao, G., Hu, Y., Jin, H., Jin, Z., Li, C., Li, H., Li, J., Li, Y., Liang, Y., Liu, G., Liu, Q., Long, H., Ma, L., Shang, Y., Song, Y., Song, Z., Su, X., Sui, H., Sun, Q., Sun, Y., Tang, J., Tong, X., Wang, H., Wang, G., Wang, L., Wang, S., Xiang, L., Xiao, T., Xie, Z., Ye, L., Yu, Y., Zhang, C., Zhang, L., Zhang, S., Zheng, R., Zhi, L., Zhou, W., Zou, Y., & Maurer, M. (2021). Expert consensus on the use of omalizumab in chronic urticaria in China. The World Allergy Organization journal, 14(11), 100610. https://doi.org/10.1016/j.waojou.2021.100610
Zhao, Zuotao, et al. "Expert consensus on the use of omalizumab in chronic urticaria in China." The World Allergy Organization journal vol. 14,11 (2021): 100610. doi: https://doi.org/10.1016/j.waojou.2021.100610
Zhao Z, Cai T, Chen H, Chen L, Chen Y, Gao X, Gao X, Geng S, Guo Y, Hao F, Hao G, Hu Y, Jin H, Jin Z, Li C, Li H, Li J, Li Y, Liang Y, Liu G, Liu Q, Long H, Ma L, Shang Y, Song Y, Song Z, Su X, Sui H, Sun Q, Sun Y, Tang J, Tong X, Wang H, Wang G, Wang L, Wang S, Xiang L, Xiao T, Xie Z, Ye L, Yu Y, Zhang C, Zhang L, Zhang S, Zheng R, Zhi L, Zhou W, Zou Y, Maurer M. Expert consensus on the use of omalizumab in chronic urticaria in China. World Allergy Organ J. 2021 Dec 05;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov. PMID: 34934470; PMCID: PMC8654989.
Copy
Download .nbib